Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Equity

v3.8.0.1
Note 9 - Equity
3 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
Note
9:
Equity
 
Stock Options
 
In the
three
months ended
March 31, 2018,
the Company granted
60,000
stock options to employees with exercise prices ranging from
$4.92
-
$6.85.
 
 
Upon the completion of the Company’s IPO in
November 2014,
its stock trading price became the basis of fair value of its common stock used in determining the value of share-based awards. To the extent the value of the Company’s share-based awards involves a measure of volatility, it will rely upon the volatilities from publicly traded companies with similar business models until its common stock has accumulated enough trading history for it to utilize its own historical volatility. The expected life of the options granted is based on the average of the vesting term and the contractual term of the option. The risk-free rate for periods within the expected life of the option is based on the U.S. Treasury
10
-year yield curve in effect at the date of the grant. 
 
The Company has computed the fair value of all options granted during the
three
months ended
March 31, 2018
and
2017,
using the following assumptions:
 
    Three Months Ended March 31,
    2018   2017
Expected volatility  
42%
-
43%
 
 
42%
 
Expected dividends  
 
None
 
 
 
None
 
Expected term (years)  
 
7
 
 
 
7
 
Risk-free rate  
2.53%
to
2.63%
 
2.10%
to
2.14%
Forfeiture rate  
 
20
%
 
 
20%
 
 
The information below summarizes the stock options activity:
 
    Number of
Shares
  Weighted
Average
Exercise
Price
  Weighted
Average
Fair 
Value
  Weighted
Average
Remaining
Contractual Life
Outstanding at December 31, 2016    
953,075
    $
3.66
    $
1.86
     
6.9
 
Granted at market price    
295,286
     
4.31
     
 
     
 
 
Exercised    
(206,875
)    
1.76
     
 
     
 
 
Cancelled    
(37,570
)    
5.11
     
 
     
 
 
Outstanding at December 31, 2017    
1,003,916
    $
4.18
    $
1.87
     
8.1
 
Granted at market price    
60,000
     
5.89
     
 
     
 
 
Exercised    
(7,500
)    
3.11
     
 
     
 
 
Cancelled    
(2,605
)    
5.03
     
 
     
 
 
Outstanding at March 31, 2018    
1,053,811
    $
4.29
    $
1.93
     
8.0
 
Exercisable at March 31, 2018    
476,601
    $
4.77
    $
2.07
     
7.6
 
 
The intrinsic value of the Company’s stock options outstanding was
$2,885,475
at
March 31, 2018.
 
For the
three
months ended
March 31, 2018
and
2017,
stock-based compensation expense for stock options was
$139,172
and
$51,038,
respectively.  Unrecognized stock-based compensation expense for stock options as of
March 31, 2018
was
$867,997,
which is expected to be recognized ratably over the next
2.9
years.
 
Restricted Stock
 
The information below summaries the restricted stock activity:
 
Restricted Stock Awards   Shares
Outstanding at December 31, 2017    
63,700
 
Awards granted    
-
 
Awards vested    
-
 
Awards forfeited    
-
 
Outstanding at March 31, 2018    
63,700
 
 
For the
three
months ended
March 31, 2018
and
2017,
stock-based compensation expense for restricted stock was
$68,469
and
$44,027,
respectively. Unrecognized stock-based compensation expense for restricted stock awards as of
March 31, 2018
was
$74,772,
the majority of which will be recognized on
June 1, 2018.